Free Trial

Humana (NYSE:HUM) Shares Unloaded Rep. Gilbert Ray Cisneros, Jr.

Humana logo with Medical background

Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Humana Inc. (NYSE:HUM). In a filing disclosed on June 06th, the Representative disclosed that they had sold between $1,001 and $15,000 in Humana stock on May 30th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

  • Sold $15,001 - $50,000 in shares of SpringWorks Therapeutics NASDAQ: SWTX on 7/1/2025.
  • Purchased $1,001 - $15,000 in shares of AppLovin NASDAQ: APP on 7/1/2025.
  • Sold $1,001 - $15,000 in shares of Amdocs NASDAQ: DOX on 6/30/2025.
  • Purchased $1,001 - $15,000 in shares of CoStar Group NASDAQ: CSGP on 6/30/2025.
  • Purchased $15,001 - $50,000 in shares of CoStar Group NASDAQ: CSGP on 6/27/2025.
  • Purchased $1,001 - $15,000 in shares of Xiaomi OTCMKTS: XIACF on 6/27/2025.
  • Sold $1,001 - $15,000 in shares of ASML NASDAQ: ASML on 6/27/2025.
  • Sold $1,001 - $15,000 in shares of Willis Towers Watson Public NASDAQ: WTW on 6/26/2025.
  • Sold $1,001 - $15,000 in shares of Boston Scientific NYSE: BSX on 6/26/2025.
  • Sold $1,001 - $15,000 in shares of Liberty Media Corporation - Liberty Formula One Series C NASDAQ: FWONK on 6/26/2025.

Humana Stock Down 3.0%

NYSE:HUM traded down $7.21 on Thursday, reaching $229.91. 531,065 shares of the stock traded hands, compared to its average volume of 1,701,078. The company has a market capitalization of $27.75 billion, a price-to-earnings ratio of 16.26, a PEG ratio of 1.58 and a beta of 0.44. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.71. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $406.09. The company's fifty day simple moving average is $234.48 and its 200 day simple moving average is $256.71.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, beating analysts' consensus estimates of $10.07 by $1.51. Humana had a net margin of 1.42% and a return on equity of 14.47%. The business had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. During the same period last year, the business earned $7.23 EPS. Humana's revenue was up 8.4% compared to the same quarter last year. Equities analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in Humana by 8.9% during the 1st quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider's stock worth $3,697,222,000 after acquiring an additional 1,143,662 shares in the last quarter. Dodge & Cox grew its holdings in Humana by 5.5% during the 1st quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider's stock worth $2,845,830,000 after acquiring an additional 557,175 shares in the last quarter. Pzena Investment Management LLC grew its holdings in Humana by 6.1% during the 1st quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider's stock worth $1,013,133,000 after acquiring an additional 219,541 shares in the last quarter. Geode Capital Management LLC grew its holdings in Humana by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider's stock worth $729,658,000 after acquiring an additional 63,562 shares in the last quarter. Finally, Invesco Ltd. boosted its holdings in shares of Humana by 29.8% in the 4th quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock valued at $608,348,000 after buying an additional 550,692 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently commented on HUM. Raymond James Financial upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price target for the company in a research note on Thursday, May 1st. Robert W. Baird upped their price target on shares of Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Oppenheimer upped their target price on shares of Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. Bank of America dropped their target price on shares of Humana from $320.00 to $260.00 and set a "neutral" rating for the company in a research report on Tuesday, June 17th. Finally, Truist Financial dropped their target price on shares of Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research report on Wednesday, July 16th. Sixteen analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $282.57.

Get Our Latest Research Report on Humana

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Humana Company Profile

(Get Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Read More

Should You Invest $1,000 in Humana Right Now?

Before you consider Humana, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.

While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines